alzheimer-disease

Documents about alzheimer-disease

• Atrophy signature for alpha-synuclein copathology in Alzheimer's disease.#269580NCBI PubMed Central
• Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology.#275382NCBI PubMed Central
• Expression of GPR34 in microglia remains stable in human Alzheimer's disease.#284899NCBI PubMed Central
• Gut Microbiome Differences Between Early Alzheimer Disease and Idiopathic Normal Pressure Hydrocephalus.#297145NCBI PubMed Central
• Early syndecan-4 upregulation predicts cognitive and pathological trajectories in Alzheimer disease.#297150NCBI PubMed Central
• Nanoparticles that target nonamyloid and nontau pathways in Alzheimer's disease.#297208NCBI PubMed Central
• Uncertainty-Aware Longitudinal Forecasting of Alzheimer's Disease Progression Using Deep Learning#303275arXiv CS
• The mechanisms and strategies for Alzheimer’s disease prevention: An update.#317579NCBI PubMed Central
• Multitarget Actions of Pentacyclic Triterpenic Acids in Alzheimer's Disease: Mechanistic Insights.#317590NCBI PubMed Central
• APOE ε4 and Alzheimer's disease biomarkers in an American Indian community.#367966NCBI PubMed Central
• Aging in a highly polluted world: challenges and solutions to prevent Alzheimer's disease.#382386NCBI PubMed Central
• Modeling Alzheimer's disease with brain organoids: mechanisms, applications, and future directions.#396232NCBI PubMed Central
• Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated States#398143bioRxiv / medRxiv
• Brain PET in the era of anti-amyloid-β antibody therapy for Alzheimer disease.#404271NCBI PubMed Central
• AI-Enabled Modeling for Alzheimer's Disease Risk Prediction and Validation.#418566NCBI PubMed Central
• New Genetic Associations Between Alzheimer's Disease and Its Key Risk Factors.#420882NCBI PubMed Central
• A Neurosymbolic Approach for Explainable Early Diagnosis of Alzheimer's Disease#422245arXiv CS
• Plasma proteomic profiles of Alzheimer's disease and neurodegeneration in African cohorts.#449752NCBI PubMed Central
• An interpretable multimodal ensemble assessment framework for Alzheimer's disease cognitive staging.#472519NCBI PubMed Central
• Amyloid-PET pipeline choice influences classification of preclinical Alzheimer’s disease#478521Europe PMC
• Blood-based biomarkers and 20-year risk of clinically diagnosed Alzheimer's disease#480194bioRxiv / medRxiv
• Reduced repressive epigenetic marks, increased DNA damage and Alzheimer's disease hallmarks in the brain of humans and mice exposed to particulate urban air pollution#251777Repositorio UNAB
• Table 1_Ershiwuwei Shanhu Pill ameliorates cognitive impairment in Alzheimer’s disease mice by remodeling gut microbiota and host serum metabolites.xls#291333Figshare
• Benchmarking speech biomarkers of Alzheimer's against cognitive and neural measures#120129Europe PMC
• (Alzheimer's) dementia in adults with Down syndrome in Germany: Administrative prevalence based on a claims data analysis#333045Europe PMC
• Biological Sample Collection for Research and Biobanking#279656ClinicalTrials.gov
• Associations of lifestyle factors and genetic risk with risk and rate advancement periods of dementia#397180OSF
• Effects of mindfulness-based exercise on Parkinson's disease and Alzheimer's disease: a systematic review and meta-analysis.#455065NCBI PubMed Central
• TREM2 as a central immunometabolic hub in Alzheimer's disease: linking microglial states, lipid stress, and disease-stage-specific intervention.#457307NCBI PubMed Central
• ARRIVE 2.0 Checklist: Neuroprotective Effects of Treadmill Training on Irisin/EGR-1/PSD-95 in Alzheimer's Disease Model Item#300596Figshare
• An Examination of Lifetime Traumatic Brain Injury and Anti-Inflammatory Medication Use in the Risk for Alzheimer's Disease#433115DigitalCommons@USU
• Value-based prices of emerging disease-modifying therapies for Alzheimer's disease in 174 countries: a cost-effectiveness and threshold analysis.#182283NCBI PubMed Central
• Reblastatin as a neuroprotective agent in temporal lobe epilepsy and excitotoxic conditions of Alzheimer's disease and Parkinson's disease.#223084NCBI PubMed Central
• Genome‐ and epigenome‐wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk#388316ISTA Publications
• Therapeutic Time Window of Disease-Modifying Therapy for Early Alzheimer's Disease in Japanese Individuals: Analysis Based on J-ADNI Study.#420895NCBI PubMed Central
• Microbiota-Gut-Brain Axis in Neurodegenerative Diseases: The Role of Bacterial Amyloids#471980HAL (France)
• Non-microglial downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease-related hallmarks#10104bioRxiv / medRxiv
• Immune-proteo-metabolomic changes link to Aβ and tau pathology in Alzheimer disease.#14809NCBI PubMed Central
• Intracellular protein GBF1 displays significant associations with amyloid pathology in Alzheimer's disease.#25679NCBI PubMed Central
• Dysfunction of the episodic memory network in the Alzheimer's disease cascade#123268Europe PMC
• System changes to empower primary care in Alzheimer's disease detection and care.#143063NCBI PubMed Central
• Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing#143862bioRxiv / medRxiv
• Designing a communication strategy to promote Alzheimer's disease prevention: The CULTIVAMENTE campaign.#145792NCBI PubMed Central
• Tau pathological activity in plasma before the onset of symptomatic Alzheimer s disease#151581bioRxiv / medRxiv
• Alpha rhythm and Alzheimer's disease: Has Hans Berger's dream come true?#154483NCBI PubMed Central
• Shared Genetic Architecture Between Kidney Function and Alzheimer Disease Across Ancestries#154949bioRxiv / medRxiv
• Predicting progression of Alzheimer’s disease using blood-based multi-omics data.#170764NCBI PubMed Central
• Effect of Insulin Sensitizer Metformin on AD Biomarkers#208393ClinicalTrials.gov
• Epigenetically constrained astrocyte states underlie prefrontal cortex vulnerability in Down syndrome associated Alzheimer disease#210481bioRxiv / medRxiv
• Artificial intelligence for detection and staging of Alzheimer's disease using retinal images.#218780NCBI PubMed Central